Antibiotic management of Group A Streptococcus (GAS, Strep. pyogenes) infection in children
exp date isn't null, but text field is
Abstract
Guidance v9 (16/12/22): Antibiotic Management of Group A Streptococcus (GAS)
Purpose and scope:
Antibiotic management of Group A Streptococcus (GAS, Strep. pyogenes) infection in children age 18 and under should follow guidance issued by UK Health Security Agency (UKHSA) and Scottish Antimicrobial Prescribing Group (SAPG).
The purpose of this guidance is to provide advice to healthcare provider in all settings on suitable alternative treatments where there are disruptions in the supply chain of particular antibiotics. This guidance should be implemented in conjunction with the SAPG guidance above.
The scope of this guidance includes antibiotic choice, formulation choice, dosing information and duration of treatment.
Practical guidance on the administration of solid oral dosage forms to children is also included.
Clinical diagnosis and decision to treat is out with the scope of this guidance.
Last reviewed: 16 December 2022
Next review: 16 December 2023
Author(s): Greater Glasgow and Clyde Paediatric Antimicrobial Management Team
Version: 9
Approved By: RHC Infectious Diseases / Director of Pharmacy / Primary Care Medical Director
Document Id: 1064